These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8681772)
1. [Secondary prevention of diabetic retinopathy in type I diabetes mellitus. Dependence on retinopathy status before the intervention]. Maca T; Fasching P; Rohac M; Stur M; Schneider B; Waldhäusl W Dtsch Med Wochenschr; 1996 Mar; 121(9):257-62. PubMed ID: 8681772 [TBL] [Abstract][Full Text] [Related]
2. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629 [TBL] [Abstract][Full Text] [Related]
3. [Evolution of blood glucose control and retinopathy during long-term treatment of insulin-dependent diabetes mellitus with intraperitoneal infusion of insulin]. Jaffiol C; Jacques-Apostol D; Renard E; Millet P; Compeyre S; Lauton D; Picot MC; Bringer J Bull Acad Natl Med; 1996 Jan; 180(1):177-91; discussion 191-4. PubMed ID: 8696875 [TBL] [Abstract][Full Text] [Related]
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. ; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control. Hatz K; Minder AE; Lehmann R; Drescher T; Gerendas B; Schmidt-Erfurth U; Kaider A; Pruente C; Zulewski H Diabetes Res Clin Pract; 2019 Feb; 148():234-239. PubMed ID: 30684505 [TBL] [Abstract][Full Text] [Related]
6. Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS). Reichard P; Britz A; Carlsson P; Cars I; Lindblad L; Nilsson BY; Rosenqvist U J Intern Med; 1990 Nov; 228(5):511-7. PubMed ID: 2254723 [TBL] [Abstract][Full Text] [Related]
7. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. Reichard P; Berglund B; Britz A; Cars I; Nilsson BY; Rosenqvist U J Intern Med; 1991 Aug; 230(2):101-8. PubMed ID: 1865159 [TBL] [Abstract][Full Text] [Related]
8. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Danne T; Weber B; Hartmann R; Enders I; Burger W; Hovener G Diabetes Care; 1994 Dec; 17(12):1390-6. PubMed ID: 7882807 [TBL] [Abstract][Full Text] [Related]
10. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004 [TBL] [Abstract][Full Text] [Related]
11. The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration. Lövestam-Adrian M; Agardh E; Agardh CD Diabetes Res Clin Pract; 1999 Aug; 45(1):15-23. PubMed ID: 10499881 [TBL] [Abstract][Full Text] [Related]
12. Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. Brinchmann-Hansen O; Dahl-Jørgensen K; Sandvik L; Hanssen KF BMJ; 1992 Jan; 304(6818):19-22. PubMed ID: 1734985 [TBL] [Abstract][Full Text] [Related]
13. The influence of strict control on diabetic complications. Hanssen KF; Dahl-Jørgensen K; Brinchmann-Hansen O Acta Endocrinol Suppl (Copenh); 1985; 272():57-60. PubMed ID: 3914805 [TBL] [Abstract][Full Text] [Related]
14. Development of proliferative retinopathy in patients with long-standing insulin-dependent diabetes mellitus. Styles CJ; Dodds W; Watkins P; McHugh D; Blach R Eye (Lond); 2000 Dec; 14(Pt 6):851-4. PubMed ID: 11584841 [TBL] [Abstract][Full Text] [Related]
15. Are there any glycemic thresholds for the serious microvascular diabetic complications? Reichard P J Diabetes Complications; 1995; 9(1):25-30. PubMed ID: 7734740 [TBL] [Abstract][Full Text] [Related]
16. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. Reichard P; Nilsson BY; Rosenqvist U N Engl J Med; 1993 Jul; 329(5):304-9. PubMed ID: 8147960 [TBL] [Abstract][Full Text] [Related]
17. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Agardh CD; Agardh E; Torffvit O Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466 [TBL] [Abstract][Full Text] [Related]
18. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?]. Dorchy H Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046 [TBL] [Abstract][Full Text] [Related]
19. Good blood glucose control characterizes patients without retinopathy after long diabetes duration. Kullberg CE; Arnqvist HJ Diabet Med; 1995 Apr; 12(4):314-20. PubMed ID: 7600746 [TBL] [Abstract][Full Text] [Related]
20. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory]. Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]